Scott Galasinski: perspectives across drug development

LinkedIn caption
Scott Galasinski in conversation at ARDD 2026. 🤝 His experience spans biotech and pharma, including business development at AstraZeneca and therapeutic-development roles at Novartis, Ultragenyx and AbbVie. He is now at Elanco.
Those perspectives are part of what makes ARDD’s community valuable: researchers and industry professionals sharing the same space, with time to connect beyond the formal program. Scott’s background across scientific and business teams adds a practical medicines-development perspective to that mix.
A candid moment from a meeting that brings aging research and drug development together. 🔬
Photo credit: Donis Perkins and Alex Zhavoronkov.
#ARDD2026 #Biotech
X caption
Scott Galasinski in conversation at ARDD 2026. 🤝 Now at Elanco, his biotech and pharma background spans science, business development and rare-disease therapeutics. 🔬
Photo: Donis Perkins and Alex Zhavoronkov. #ARDD2026
Photo: Donis Perkins and Alex Zhavoronkov
Copy and paste the caption manually, then attach the downloaded photo. Nothing is published automatically.